TGFB1 and systemic sclerosis: In addition to the higher levels of TGF-β observed in SSc, SSc fibroblasts present an increased expression of type I and type II TGF-β receptors along with alterations in TGF-β pathways, which render them hyperresponsive to TGF-β, further enhancing their pro-fibrotic response [6,7].